228 related articles for article (PubMed ID: 37061233)
1. Patient-Reported Outcomes in Calcium Pyrophosphate Deposition Disease Compared to Gout and Osteoarthritis.
Whelan MG; Hayashi K; Altwies H; Tedeschi SK
J Rheumatol; 2023 Aug; 50(8):1058-1062. PubMed ID: 37061233
[TBL] [Abstract][Full Text] [Related]
2. Towards development of core domain sets for short term and long term studies of calcium pyrophosphate crystal deposition (CPPD) disease: A framework paper by the OMERACT CPPD working group.
Cai K; Fuller A; Zhang Y; Hensey O; Grossberg D; Christensen R; Shea B; Singh JA; McCarthy GM; Rosenthal AK; Filippou G; Taylor WJ; Diaz-Torne C; Stamp LK; Edwards NL; Pascart T; Becce F; Nielsen SM; Tugwell P; Beaton D; Abhishek A; Tedeschi SK; Dalbeth N
Semin Arthritis Rheum; 2021 Aug; 51(4):946-950. PubMed ID: 34140183
[TBL] [Abstract][Full Text] [Related]
3. Calcium pyrophosphate deposition disease: clinical manifestations.
Ferrone C; Andracco R; Cimmino MA
Reumatismo; 2012 Jan; 63(4):246-52. PubMed ID: 22303531
[TBL] [Abstract][Full Text] [Related]
4. Cartilage icing and chondrocalcinosis on knee radiographs in the differentiation between gout and calcium pyrophosphate deposition.
Falkowski AL; Jacobson JA; Kalia V; Meyer NB; Gandikota G; Yosef M; Thiele RG
PLoS One; 2020; 15(4):e0231508. PubMed ID: 32298308
[TBL] [Abstract][Full Text] [Related]
5. Management of calcium pyrophosphate crystal deposition disease: A systematic review.
Parperis K; Papachristodoulou E; Kakoullis L; Rosenthal AK
Semin Arthritis Rheum; 2021 Feb; 51(1):84-94. PubMed ID: 33360232
[TBL] [Abstract][Full Text] [Related]
6. Ankylosing spondylitis, late osteoarthritis, vascular calcification, chondrocalcinosis and pseudo gout: toward a possible drug therapy.
Mebarek S; Hamade E; Thouverey C; Bandorowicz-Pikula J; Pikula S; Magne D; Buchet R
Curr Med Chem; 2011; 18(14):2196-203. PubMed ID: 21517761
[TBL] [Abstract][Full Text] [Related]
7. Update on calcium pyrophosphate deposition.
Abhishek A; Doherty M
Clin Exp Rheumatol; 2016; 34(4 Suppl 98):32-8. PubMed ID: 27586801
[TBL] [Abstract][Full Text] [Related]
8. Synovial fluid calcium pyrophosphate dihydrate crystals and alizarin red positivity: analysis of 3000 samples.
Hamilton E; Pattrick M; Hornby J; Derrick G; Doherty M
Br J Rheumatol; 1990 Apr; 29(2):101-4. PubMed ID: 2157516
[TBL] [Abstract][Full Text] [Related]
9. Review: Unmet Needs and the Path Forward in Joint Disease Associated With Calcium Pyrophosphate Crystal Deposition.
Abhishek A; Neogi T; Choi H; Doherty M; Rosenthal AK; Terkeltaub R
Arthritis Rheumatol; 2018 Aug; 70(8):1182-1191. PubMed ID: 29609209
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound findings of calcium pyrophosphate deposition disease at metacarpophalangeal joints.
Cipolletta E; Di Matteo A; Smerilli G; Di Carlo M; Di Battista J; Abhishek A; Grassi W; Filippucci E
Rheumatology (Oxford); 2022 Oct; 61(10):3997-4005. PubMed ID: 35104308
[TBL] [Abstract][Full Text] [Related]
11. Outcome domains reported in calcium pyrophosphate deposition studies: A scoping review by the OMERACT CPPD working group.
Cai K; Fuller A; Hensey O; Grossberg D; Christensen R; Shea B; Singh JA; Abhishek A; Tedeschi S; Dalbeth N
Semin Arthritis Rheum; 2020 Aug; 50(4):719-727. PubMed ID: 32521326
[TBL] [Abstract][Full Text] [Related]
12. Experience and impact of crystal pyrophosphate deposition (CPPD) from a patient and caregiver perspective: A qualitative exploration from the OMERACT CPPD working group.
Fuller A; Cai K; Filippou G; Pascart T; Diaz-Torne C; Hensey O; Grossberg D; Christensen R; Shea B; Singh JA; Tedeschi SK; Dalbeth N; Abhishek A
Semin Arthritis Rheum; 2021 Jun; 51(3):655-660. PubMed ID: 33941385
[TBL] [Abstract][Full Text] [Related]
13. Calcium pyrophosphate deposition (CPPD) disease - Treatment options.
Stack J; McCarthy G
Best Pract Res Clin Rheumatol; 2021 Dec; 35(4):101720. PubMed ID: 34756508
[TBL] [Abstract][Full Text] [Related]
14. Calcium pyrophosphatase dihydrate (CPPD) crystal deposition disease in a teaching hospital in Kuwait.
Malaviya AN; Al-Shari IM; Al-Shayeb AR; Shehab D; Hussain MA; Al-Mutairy M; Roberts OM; Al-Ghuriear S
Ann Rheum Dis; 2001 Apr; 60(4):416-9. PubMed ID: 11247877
[TBL] [Abstract][Full Text] [Related]
15. Local deposition of calcium pyrophosphate crystals in evolution of knee osteoarthritis.
Reuge L; Van Linthoudt D; Gerster JC
Clin Rheumatol; 2001; 20(6):428-31. PubMed ID: 11771528
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of calcium pyrophosphate deposition disease in a cohort of patients diagnosed with seronegative rheumatoid arthritis.
Paalanen K; Rannio K; Rannio T; Asikainen J; Hannonen P; Sokka T
Clin Exp Rheumatol; 2020; 38(1):99-106. PubMed ID: 31140401
[TBL] [Abstract][Full Text] [Related]
17. Crystal induced arthritis: gout and pseudogout.
Webb J
Aust Fam Physician; 1978 Aug; 7(8):959-80. PubMed ID: 708317
[TBL] [Abstract][Full Text] [Related]
18. Pathogenesis of calcium pyrophosphate deposition disease.
Williams CJ; Rosenthal AK
Best Pract Res Clin Rheumatol; 2021 Dec; 35(4):101718. PubMed ID: 34696986
[TBL] [Abstract][Full Text] [Related]
19. Dual-Energy Computed Tomography Demonstrating Destructive Calcium Pyrophosphate Deposition Disease of the Distal Radioulnar Joint Mimicking Tophaceous Gout.
Ward IM; Scott JN; Mansfield LT; Battafarano DF
J Clin Rheumatol; 2015 Sep; 21(6):314-7. PubMed ID: 26267716
[TBL] [Abstract][Full Text] [Related]
20. Calcium pyrophosphate deposition disease: a review of epidemiologic findings.
Abhishek A
Curr Opin Rheumatol; 2016 Mar; 28(2):133-9. PubMed ID: 26626724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
